AstraZeneca buys cell therapy biotech in up to $1bn deal
London-listed pharmaceuticals group expands investments in cancer cell therapies with EsoBiotec acquisition

Mar 15, 2025 0
Mar 8, 2025 0
Mar 15, 2025 0
Mar 16, 2025 0
Mar 16, 2025 0
Mar 16, 2025 0
Mar 17, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Mar 17, 2025 0
Mar 17, 2025 0
Mar 17, 2025 0
Mar 14, 2025 0
Or register with email
Feb 9, 2025 0
Feb 10, 2025 0
Feb 11, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 13, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.